Cargando…
Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma
Recent studies demonstrated that CD155 plays an important role in anti-tumor immune responses. However, its role in glioma remains unclear. Here, we identify CD155 as a promising immune target in glioma. CD155 expression was significantly highly expressed in glioblastoma but not in normal brain tiss...
Autores principales: | Liu, Fangkun, Huang, Jing, Xiong, Yuanyuan, Li, Shuwang, Liu, Zhixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710042/ https://www.ncbi.nlm.nih.gov/pubmed/31377744 http://dx.doi.org/10.18632/aging.102131 |
Ejemplares similares
-
Role of CD68 in tumor immunity and prognosis prediction in pan-cancer
por: Zhang, Jingwei, et al.
Publicado: (2022) -
Large-Scale Analysis Reveals the Specific Clinical and Immune Features of DGCR5 in Glioma
por: Wu, Xuechao, et al.
Publicado: (2020) -
CTLA-4 correlates with immune and clinical characteristics of glioma
por: Liu, Fangkun, et al.
Publicado: (2020) -
Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021) -
Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas
por: Zhang, Jingwei, et al.
Publicado: (2022)